|
||||||||||||||||||||||||||||||||||
[發(fā)表評(píng)論] [本類其他產(chǎn)品] [本類其他供應(yīng)商] [收藏] |
銷售商: 上海皓元生物醫(yī)藥科技有限公司 | 查看該公司所有產(chǎn)品 >> |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
EtodolacCAS No. : 41340-25-4
MCE 國際站:Etodolac
產(chǎn)品活性:Etodolac (AY-24236) 是非甾體抗炎化合物,對(duì) COX 的 IC50為53.5 nM。
研究領(lǐng)域:Immunology/Inflammation
作用靶點(diǎn):COX
In Vitro: Post-marketing studies demonstrated that etodolac inhibition of cyclooxygenase is somewhat COX-2 selective similar to celecoxib and other "COX-2 inhibitors." Unlike rofecoxib, both etodolac and celecoxib can fully inhibit COX-1 and are designated as having "preferential selectivity" toward COX-2. The (inactive against COX) r-enantiomer of etodolac inhibits beta-catenin levels in hepatoma cells.
相關(guān)產(chǎn)品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | FDA-Approved Drug Library | Anti-Cancer Compound Library | CNS-Penetrant Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | Pyroptosis Compound Library | Orally Active Compound Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Anti-Pancreatic Cancer Compound Library | Acetaminophen | Indomethacin | Celecoxib | Aspirin | Ibuprofen | Catechin | NS-398 | 20(S)-Ginsenoside Rg3 | Naproxen | Diclofenac Sodium | Sulindac | (-)-Epicatechin | SC-560 | Gallic acid | Carprofen | Salicylic acid | Xanthohumol | Rutaecarpine | Meloxicam | Rebamipide | Iguratimod | Rofecoxib | Neochlorogenic acid | Fenofibric acid | Nabumetone | Piroxicam | Flufenamic acid
品牌介紹:
• MCE (MedChemExpress) 擁有數(shù)百種全球獨(dú)家化合物,我們致力于為全球科研客戶提供最新最全的高品質(zhì)小分子活性化合物;
• 10,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門信號(hào)通路及疾病領(lǐng)域;
• 設(shè)有專業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控、驗(yàn)證體系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各項(xiàng)質(zhì)檢報(bào)告,確保產(chǎn)品的高純度、高品質(zhì);
• 產(chǎn)品的生物活性多經(jīng)各國客戶實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥專利收錄了MCE客戶的科研成果;
• 專業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,為您提供全球最新的活性化合物;
• 與世界各大制藥公司及知名科研機(jī)構(gòu)建立了長期的合作。